Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helicobacter pylori eradication in children with nephrotic syndrome
IRCT20120215009014N268Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of omeprazole, metronidazole, ampicillin and bismuth subcitrate in Helicobacter pylori infection and nephrosis (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Proteinuria. Started Mar 2019; status: completed.
02
Drugs
omeprazolemetronidazoleampicillinbismuth subcitrate
03
Conditions
Helicobacter pylori infectionnephrosis
Beyond the preview
Go deeper on IRCT20120215009014N268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N268.